We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

192 hedge funds and large institutions have $1.74B invested in Cytokinetics in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 62 increasing their positions, 63 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 17

65% more call options, than puts

Call options by funds: $5.35M | Put options by funds: $3.23M

15% more capital invested

Capital invested by funds: $1.51B → $1.74B (+$224M)

8% more funds holding

Funds holding: 178 → 192 (+14)

2.22% more ownership

Funds ownership: 103.03% → 105.26% (+2.2%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

2% less repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 63

Holders
192
Holders Change
+14
Holders Change %
+7.87%
% of All Funds
3.37%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
32
Increased
62
Reduced
63
Closed
17
Calls
$5.35M
Puts
$3.23M
Net Calls
+$2.11M
Net Calls Change
-$5.53M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$59.9M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$33.1M
3
LGM
Logos Global Management
California
+$14.9M
4
CCM
CAAS Capital Management
New York
+$14.3M
5
MWNA
Marshall Wace North America
New York
+$13.5M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$101M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$16.9M
3
PCH
Polar Capital Holdings
United Kingdom
-$12.8M
4
FCMI
Foresite Capital Management IV
California
-$11.8M
5
State Street
State Street
Massachusetts
-$10.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
76
UBS Group
Switzerland
$2.05M +$1.82M +85,091 +2,690%
Wells Fargo
77
Wells Fargo
California
$1.91M -$1.62M -75,844 -48%
CSS
78
Cubist Systematic Strategies
Connecticut
$1.9M +$1.53M +71,714 +723%
Comerica Bank
79
Comerica Bank
Texas
$1.9M -$50.7K -2,373 -3%
BCPEMI
80
Bain Capital Public Equity Management II
Massachusetts
$1.89M +$1.74M +81,366 New
Prudential Financial
81
Prudential Financial
New Jersey
$1.88M +$9.61K +450 +0.6%
ERSOT
82
Employees Retirement System of Texas
Texas
$1.75M – – –
Macquarie Group
83
Macquarie Group
Australia
$1.74M +$95.4K +4,469 +6%
IIM
84
Ironwood Investment Management
Massachusetts
$1.61M -$14.2K -667 -1%
Ohio Public Employees Retirement System (OPERS)
85
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.55M – – –
UBS AM
86
UBS AM
Illinois
$1.48M +$210K +9,842 +18%
Canada Life
87
Canada Life
Manitoba, Canada
$1.42M -$143K -6,704 -10%
New York State Common Retirement Fund
88
New York State Common Retirement Fund
New York
$1.4M – – –
Thrivent Financial for Lutherans
89
Thrivent Financial for Lutherans
Minnesota
$1.36M -$3.65K -171 -0.3%
MS
90
Maven Securities
Jersey
$1.33M +$469K +21,941 +62%
COPPSERS
91
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.28M +$256 +12 +0%
Susquehanna International Group
92
Susquehanna International Group
Pennsylvania
$1.27M +$19.6K +916 +2%
ECM
93
ExodusPoint Capital Management
New York
$1.24M +$1.14M +53,486 New
TPSF
94
Texas Permanent School Fund
Texas
$1.24M -$79.1K -3,705 -7%
First Trust Advisors
95
First Trust Advisors
Illinois
$1.15M +$226K +10,583 +27%
SOADOR
96
State of Alaska Department of Revenue
Alaska
$1.11M -$152K -7,120 -13%
Tudor Investment Corp
97
Tudor Investment Corp
Connecticut
$1.06M +$978K +45,792 New
Deutsche Bank
98
Deutsche Bank
Germany
$1.03M -$96.5K -4,517 -9%
State of Tennessee, Department of Treasury
99
State of Tennessee, Department of Treasury
Tennessee
$984K -$33.2K -1,556 -4%
AAA
100
Affinity Asset Advisors
New York
$930K -$641K -30,000 -43%
2 3
4
5 6

CYTK Hedge Fund Activity: Q1 2021 in Review

192 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q1 2021, worth a combined $1.74B — up 15% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new CYTK positions and 17 closed out — a net gain of 15 holders — while 62 added to existing stakes and 63 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $59.9M. The largest seller was BVF Inc, exiting entirely with an estimated $101M sold.

  • 192 institutional investors held Cytokinetics (CYTK) as of Q1 2021, up from 178 in Q4 2020.
  • Funds reported $1.74B of Cytokinetics stock for Q1 2021, up 15% quarter-over-quarter.
  • 32 funds opened new Cytokinetics positions in Q1 2021 and 17 closed out, a net change of +15 holders.
  • The largest Cytokinetics buyer in Q1 2021 was Fidelity Investments, an estimated $59.9M added.
  • The largest Cytokinetics seller in Q1 2021 was BVF Inc, an estimated $101M sold.

Based on aggregated 13F filings for Q1 2021.